Corresponding Author: Beth P. Bell, MD, MPH, Department of Global Health, University of Washington, Box 357965, Seattle, WA 98195 (bzb8@uw.edu).
Published Online: October 22, 2020. doi:10.1001/jama.2020.20847
Conflict of Interest Disclosures: None reported.
Additional Information: In addition to the authors, voting members of ACIP include Robert L. Atmar, MD, Kevin A. Ault, MD, Lynn Bahta, RN, MPH, Henry Bernstein, DO, Sharon E. Frey, MD, Paul Hunter, MD, Veronica V. McNally, JD, Katherine A. Poehling, MD, Pablo J. Sánchez, MD, Peter G. Szilagyi, MD, and Helen Keipp Talbot, MD. This Viewpoint reflects the opinion of the entire committee.
3.National Academies of Sciences, Engineering, and Medicine. Framework for Equitable Allocation of COVID-19 Vaccine. National Academies Press; 2020.
5.National Center for Health Statistics. National Health Interview Survey. US Dept of Health and Human Services; 2016. Accessed September 21, 2020.
https://www.cdc.gov/nchs/nhis
8.Bauchner
H , Malani
PN , Sharfstein
J . Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine.
JAMA. Published online September 10, 2020. doi:
10.1001/jama.2020.18860PubMedGoogle Scholar